Excuse the negativity, but I really am very disappointed and can't find many positives. Some are hoping that the new CEO will come in and change things around, but let's all be realistic:
1. A good CEO is likely to be very expensive. Now, do we really want such a CEO given the funding constraints? And do we need to pay a CEO multiples of what GK was paid to do possibly less?
2. In any case, why on earth would a high calibre CEO want the role at NRT, a small biotech with clear history of the board over-ruling the CEO? This could be a career ending role. Honestly, despite the claims of high calibre candidates, only people I can see applying are those who may have already retired or about to retire, since these people don't have to think about the next role.
There, I feel better now...
- Forums
- ASX - By Stock
- Ann: Novogen Announces Outcome of Comprehensive Science Review
Excuse the negativity, but I really am very disappointed and...
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)